Drug Trial Radar · NCT04918771
Clinical Study of Efficacy and Safety of Raphamin in the Treatment of ARVI in Children 12-18 Years Old
Last checked: Nov 19, 2026Latest source record: Oct 15, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
435
Actual
Start
Apr 29, 2021
Primary completion
Jul 21, 2023
Study completion Jul 21, 2023
Sponsor
- Lead sponsor
- Materia Medica HoldingIndustry
- Sponsor type
- Industry
- First posted
- Jun 9, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 12 years, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The multicenter double-blind placebo-controlled randomized in parallel-group. The objective of this study is to evaluate efficacy and safety of Raphamin in the treatment of acute respiratory viral infection (ARVI) in children aged 12-18 years old.
Conditions
- Acute Respiratory Viral Infection
Interventions
RaphaminDrug
Oral administration - not with food. Keep the tablet in the mouth until it is completely dissolved. On the 1st day of treatment, 8 tablets are taken according to the following scheme: 1 tablet every 30 minutes in the first 2 hours (a total of 5 tablets in 2 hours), then during the same day, take another 1 tablet 3 times at regular intervals. On the 2nd day and then take 1 tablet 3 times a day. The duration of treatment is 5 days.
PlaceboDrug
Oral administration - not with food. Placebo using Raphamin scheme.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to Resolution of Acute Respiratory Viral Infection (ARVI) Symptoms (ARVI, Confirmed by Polymerase Chain Reaction (PCR)).Time frame: 14 days of observation
Locations
29 sites in 1 country. Site status is shown where the registry gives one.
Kazan State Medical University
Kazan', Russia
Llc "Medlight"
Kazan', Russia
Specialized Clinical Hospital for Infectious Diseases
Krasnodar, Russia
Llc "Olla-Med"
Moscow, Russia
Russian National Research Medical University named after N.I. Pirogov
Moscow, Russia
Morozovskaya Children's City Clinical Hospital of the Moscow Department of Health
Moscow, Russia
Federal Scientific and Clinical Center for Physical and Chemical Medicine of the Federal Medical and Biological Agency
Moscow, Russia
Llc "Diagnostics and Vaccines"
Moscow, Russia
Novosibirsk State Medical University
Novosibirsk, Russia
City Children's Clinical Polyclinic # 5
Perm, Russia
LLC "Professorial Clinic"
Perm, Russia
Clinical and diagnostic center "Health" of the city of Rostov-on-Don
Rostov-on-Don, Russia
Children's City Hospital #1 of Rostov-on-Don city
Rostov-on-Don, Russia
Rostov State Medical University
Rostov-on-Don, Russia
Ryazan State Medical University named after academician I.P. Pavlov
Ryazan, Russia
Children's city polyclinic # 44
Saint Petersburg, Russia
LLC "Energy of health"
Saint Petersburg, Russia
Children's city polyclinic # 35
Saint Petersburg, Russia
Research Institute of Influenza named after A.A. Smorodintsev
Saint Petersburg, Russia
Samara Regional Children's Clinical Hospital named after N.N. Ivanova
Samara, Russia
National Research Mordovian State University named after N.P. Ogarev
Saransk, Russia
LLC "DNA Research Center"
Saratov, Russia
Smolensk State Medical University
Smolensk, Russia
Bashkir State Medical University/Department of Outpatient and Emergency Pediatrics
Ufa, Russia
Volgograd State Medical University/Department of Pediatrics and Neonatology
Volgograd, Russia
Yaroslavl State Medical University/Department of Pediatrics IPGE
Yaroslavl, Russia
Yaroslavl State Medical University/Department of Pediatrics № 2
Yaroslavl, Russia
Clinical Hospital # 2
Yaroslavl, Russia
LLC "European Medical Center "UMMC-Health"
Yekaterinburg, Russia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.